Ethanol withdrawal-induced brain metabolites and the pharmacological effects of acamprosate in mice lacking ENT1

Neuropharmacology

Volumn 62, Issue 8, 2012, Pages 2480-2488

  Hinton, David J ^a   Lee, Moonnoh R ^a   Jacobson, Taylor L ^a   Mishra, Prasanna K ^a   Frye, Mark A ^b   Mrazek, David A ^b   Macura, Slobodan I ^a   Choi, Doo Sup ^a,b  

^a MAYO GRADUATE SCHOOL   (United States)

^b Mayo Clinic College of Medicine   (United States)

Author keywords

1H MRS; Acamprosate; ENT1; Ethanol withdrawal; GABA; Glutamate

Indexed keywords

4 AMINOBUTYRIC ACID; ACAMPROSATE; CHOLINE; EQUILIBRATIVE NUCLEOSIDE TRANSPORTER 1; GLUTAMIC ACID; GLUTAMINE;

ALCOHOL WITHDRAWAL; ALCOHOLISM; AMINO ACID BRAIN LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN METABOLISM; CONTROLLED STUDY; DRUG MECHANISM; GENOTYPE; IN VIVO STUDY; MOUSE; NONHUMAN; NUCLEUS ACCUMBENS; PREFRONTAL CORTEX; PRIORITY JOURNAL; WILD TYPE;

ANIMALS; BRAIN; EQUILIBRATIVE NUCLEOSIDE TRANSPORTER 1; ETHANOL; GAMMA-AMINOBUTYRIC ACID; GLUTAMIC ACID; MAGNETIC RESONANCE SPECTROSCOPY; MICE; MICE, KNOCKOUT; PHOSPHORYLATION; SUBSTANCE WITHDRAWAL SYNDROME; TAURINE;

EID: 84862807936     PISSN: 00283908     EISSN: 18737064     Source Type: Journal    
DOI: 10.1016/j.neuropharm.2012.02.022     Document Type: Article

References (72)

1. Addolorato, G., Caputo, F., Capristo, E., Domenicali, M., Bernardi, M., Janiri, L., Agabio, R., Colombo, G., Gessa, G.L., Gasbarrini, G., 2002. Baclofen efficacy in reducing alcohol craving and intake: a preliminary double-blind randomized controlled study. Alcohol Alcohol. 37, 504-508.
2. Adinoff, B., Kramer, G.L., Petty, F., 1995. Levels of gamma-aminobutyric acid in cerebrospinal fluid and plasma during alcohol withdrawal. Psychiatry Res. 59, 137-144. (Pubitemid 26024510)
3. Anton, R.F., Swift, R.M., 2003. Current pharmacotherapies of alcoholism: a U.S. perspective. Am. J. Addict.. 12 (Suppl. 1), S53eS68.
4. Anton, R.F., O'Malley, S.S., Ciraulo, D.A., Cisler, R.A., Couper, D., Donovan, D.M., Gastfriend, D.R., Hosking, J.D., Johnson, B.A., LoCastro, J.S., Longabaugh, R., Mason, B.J., Mattson, M.E., Miller, W.R., Pettinati, H.M., Randall, C.L., Swift, R., Weiss, R.D., Williams, L.D., Zweben, A., 2006. Combined pharmacotherapies and behavioral interventions for alcohol dependence: the COMBINE study: a randomized controlled trial. J. Am. Med. Assoc. 295, 2003-2017. (Pubitemid 44794003)
5. Becker, H.C., Diaz-Granados, J.L., Weathersby, R.T., 1997. Repeated ethanol withdrawal experience increases the severity and duration of subsequent withdrawal seizures in mice. Alcohol 14, 319-326. (Pubitemid 27274736)
6. Bolo, N., Nedelec, J.F., Muzet, M., De Witte, P., Dahchour, A., Durbin, P., Macher, J.P., 1998. Central effects of acamprosate: part 2. Acamprosate modifies the brain in-vivo proton magnetic resonance spectrum in healthy young male volunteers. Psychiatry Res. 82, 115-127. (Pubitemid 28341672)
7. Breslin, F.J., Johnson, B.A., Lynch, W.J., 2010. Effect of topiramate treatment on ethanol consumption in rats. Psychopharmacology 207, 529-534.
8. Chen, J., Nam, H.W., Lee, M.R., Hinton, D.J., Choi, S., Kim, T., Kawamura, T., Janak, P.H., Choi, D.-S., 2010. Altered glutamatergic neurotransmission in the striatum regulates ethanol sensitivity and intake in mice lacking ENT1. Behav. Brain Res. 208, 636-642.
9. Choi, D.S., Cascini, M.G., Mailliard, W., Young, H., Paredes, P., McMahon, T., Diamond, I., Bonci, A., Messing, R.O., 2004. The type 1 equilibrative nucleoside transporter regulates ethanol intoxication and preference. Nat. Neurosci. 7, 855-861. (Pubitemid 38989509)
10. Choi, J.K., Dedeoglu, A., Jenkins, B.G., 2007. Application of MRS to mouse models of neurodegenerative illness. NMR Biomed. 20, 216-237. (Pubitemid 46830264)
11. Collins, P.Y., Patel, V., Joestl, S.S., March, D., Insel, T.R., Daar, A.S., Anderson, W., Dhansay, M.A., Phillips, A., Shurin, S., Walport, M., Ewart, W., Savill, S.J., Bordin, I.A., Costello, E.J., Durkin, M., Fairburn, C., Glass, R.I., Hall, W., Huang, Y., Hyman, S.E., Jamison, K., Kaaya, S., Kapur, S., Kleinman, A., Ogunniyi, A., Otero-Ojeda, A., Poo, M.M., Ravindranath, V., Sahakian, B.J., Saxena, S., Singer, P.A., Stein, D.J., 2011. Grand challenges in global mental health. Nature 475, 27-30.
12. Colombo, G., Serra, S., Brunetti, G., Atzori, G., Pani, M., Vacca, G., Addolorato, G., Froestl, W., Carai, M.A., Gessa, G.L., 2002. The GABA(B) receptor agonists baclofen and CGP 44532 prevent acquisition of alcohol drinking behaviour in alcohol-preferring rats. Alcohol Alcohol. 37, 499-503.
13. D'Souza El-Guindy, N.B., Kovacs, E.J., De Witte, P., Spies, C., Littleton, J.M., de Villiers, W.J., Lott, A.J., Plackett, T.P., Lanzke, N., Meadows, G.G., 2010. Laboratory models available to study alcohol-induced organ damage and immune variations: choosing the appropriate model. Alcohol. Clin. Exp. Res. 34, 1489-1511.
14. Dahchour, A., De Witte, P., 1999. Acamprosate decreases the hypermotility during repeated ethanol withdrawal. Alcohol 18, 77-81. (Pubitemid 29269903)
15. Dahchour, A., De Witte, P., 2000. Ethanol and amino acids in the central nervous system: assessment of the pharmacological actions of acamprosate. Prog. Neurobiol. 60, 343-362.
16. Dahchour, A., De Witte, P., 2003. Excitatory and inhibitory amino acid changes during repeated episodes of ethanol withdrawal: an in vivo microdialysis study. Eur. J. Pharmacol. 459, 171-178. (Pubitemid 36078318)
17. Dahchour, A., De Witte, P., Bolo, N., Nedelec, J.F., Muzet, M., Durbin, P., Macher, J.P., 1998. Central effects of acamprosate: part 1. Acamprosate blocks the glutamate increase in the nucleus accumbens microdialysate in ethanol withdrawn rats. Psychiatry Res. 82, 107-114. (Pubitemid 28341671)
18. Daoust, M., Legrand, E., Gewiss, M., Heidbreder, C., DeWitte, P., Tran, G., Durbin, P., 1992. Acamprosate modulates synaptosomal GABA transmission in chronically alcoholised rats. Pharmacol. Biochem. Behav. 41, 669-674.
19. De Witte, P., 2004. Imbalance between neuroexcitatory and neuroinhibitory amino acids causes craving for ethanol. Addict. Behav. 29, 1325-1339. (Pubitemid 39165992)
20. De Witte, P., Littleton, J., Parot, P., Koob, G., 2005. Neuroprotective and abstinence-promoting effects of acamprosate: elucidating the mechanism of action. CNS Drugs 19, 517-537. (Pubitemid 41058377)
21. 1H NMR spectroscopy of the human brain at 9.4 T: initial results. J. Mag. Res. 206, 74-80.
22. Ende, G., Welzel, H., Walter, S., Weber-Fahr, W., Diehl, A., Hermann, D., Heinz, A., Mann, K., 2005. Monitoring the effects of chronic alcohol consumption and abstinence on brain metabolism: a longitudinal proton magnetic resonance spectroscopy study. Biol. Psychiatry 58, 974-980. (Pubitemid 41790708)
23. Faingold, C., Li, Y., Evans, M.S., 2000. Decreased GABA and increased glutamate receptor-mediated activity on inferior colliculus neurons in vitro are associated with susceptibility to ethanol withdrawal seizures. Brain Res. 868, 287-295. (Pubitemid 30347525)
24. Franklin, K.B.J., Paxinos, G., 2008. The Mouse Brain Stereotaxic Coordinates, Compact third ed. Elsevier Academic Press, San Diego, CA.
25. Gass, N., Ollila, H.M., Utge, S., Partonen, T., Kronholm, E., Pirkola, S., Suhonen, J., Silander, K., Porkka-Heiskanen, T., Paunio, T., 2010. Contribution of adenosine related genes to the risk of depression with disturbed sleep. J. Affect. Disord. 126, 134-139.
26. Gazdzinski, S., Durazzo, T.C., Weiner, M.W., Meyerhoff, D.J., 2008. Are treated alcoholics representative of the entire population with alcohol use disorders? A magnetic resonance study of brain injury. Alcohol 42, 67-76. (Pubitemid 351389738)
27. Hall, W., Zador, D., 1997. The alcohol withdrawal syndrome. Lancet 349, 1897-1900. (Pubitemid 27270131)
28. Hermann, D., Weber-Fahr, W., Sartorius, A., Hoerst, M., Frischknecht, U., Tunc-Skarka, N., Perreau-Lenz, S., Hansson, A.C., Krumm, B., Kiefer, F., Spanagel, R., Mann, K., Ende, G., Sommer, W.H., in press. Translational magnetic resonance spectroscopy reveals excessive central glutamate levels during alcohol withdrawal in humans and rats. Biol. Psychiatry.
29. Holmes, A., 2011. Merger fever: can two separate mechanisms work together to explain why we drink? Biol. Psychiatry 69, 1015-1016.
30. Jagannathan, N.R., Desai, N.G., Raghunathan, P., 1996. Brain metabolite changes in alcoholism: an in vivo proton magnetic resonance spectroscopy (MRS) study. Magn. Reson. Imaging 14, 553-557. (Pubitemid 26274846)
31. Jensen, J.E., Licata, S.C., Ongur, D., Friedman, S.D., Prescot, A.P., Henry, M.E., Renshaw, P.F., 2009. Quantification of J-resolved proton spectra in two-dimensions with LCModel using GAMMA-simulated basis sets at 4 Tesla. NMR Biomed. 22, 762-769.
32. Kalivas, P.W., Volkow, N.D., 2011. New medications for drug addiction hiding in glutamatergic neuroplasticity. Mol. Psychiatry 16, 974-986.
33. Kenna, G.A., Lomastro, T.L., Schiesl, A., Leggio, L., Swift, R.M., 2009. Review of topiramate: an antiepileptic for the treatment of alcohol dependence. Curr. Drug Abuse Rev. 2, 135-142.
34. Kim, J.H., Karpyak, V.M., Biernacka, J.M., Nam, H.W., Lee, M.R., Preuss, U.W., Zill, P., Yoon, G., Colby, C., Mrazek, D.A., Choi, D.S., 2011. Functional role of the polymorphic 647 T/C variant of ENT1 (SLC29A1) and its association with alcohol withdrawal seizures. PLoS One 6, -16331.
35. Lee, H., Holburn, G.H., Price, R.R., 2003. Proton MR spectroscopic studies of chronic alcohol exposure on the rat brain. J. Magn. Reson. Imaging 18, 147-151. (Pubitemid 36935944)
36. Lee, M.R., Hinton, D.J., Wu, J., Mishra, P.K., Port, J.D., Macura, S.I., Choi, D.S., 2011. Acamprosate reduces ethanol drinking behaviors and alters the metabolite profile in mice lacking ENT1. Neurosci. Lett. 490, 90-95.
37. Li, S.P., Park, M.S., Jin, G.Z., Kim, J.H., Lee, H.L., Lee, Y.L., Bahk, J.Y., Park, T.J., Koh, P.O., Chung, B.C., Kim, M.O., 2005. Ethanol modulates GABA(B) receptor expression in cortex and hippocampus of the adult rat brain. Brain Res. 1061, 27-35. (Pubitemid 41532343)
38. Licata, S.C., Renshaw, P.F., 2010. Neurochemistry of drug action: insights from proton magnetic resonance spectroscopic imaging and their relevance to addiction. Annu. N. Y. Acad. Sci. 1187, 148-171.
39. Maccioni, P., Bienkowski, P., Carai, M.A., Gessa, G.L., Colombo, G., 2008. Baclofen attenuates cue-induced reinstatement of alcohol-seeking behavior in Sardinian alcohol-preferring (sP) rats. Drug Alcohol Depend. 95, 284-287.
40. Mann, K., 2004. Pharmacotherapy of alcohol dependence: a review of the clinical data. CNS Drugs 18, 485-504. (Pubitemid 38829945)
41. Mann, K., Lehert, P., Morgan, M.Y., 2004. The efficacy of acamprosate in the maintenance of abstinence in alcohol-dependent individuals: results of a metaanalysis. Alcohol. Clin. Exp. Res. 28, 51-63. (Pubitemid 38114023)
42. Mann, K., Kiefer, F., Spanagel, R., Littleton, J., 2008. Acamprosate: recent findings and future research directions. Alcohol. Clin. Exp. Res. 32, 1105-1110.
43. Mason, G.F., Petrakis, I.L., de Graaf, R.A., Gueorguieva, R., Guidone, E., Coric, V., Epperson, C.N., Rothman, D.L., Krystal, J.H., 2006. Cortical gamma-aminobutyric acid levels and the recovery from ethanol dependence: preliminary evidence of modification by cigarette smoking. Biol. Psychiatry 59, 85-93. (Pubitemid 43005239)
44. McCown, T.J., Breese, G.R., 1993. A potential contribution to ethanol withdrawal kindling: reduced GABA function in the inferior collicular cortex. Alcohol. Clin. Exp. Res. 17, 1290-1294. (Pubitemid 24112489)
45. Melendez, R.I., Kalivas, P.W., 2004. Last call for adenosine transporters. Nat. Neurosci. 7, 795-796. (Pubitemid 38989498)
46. Metten, P., Sorensen, M.L., Cameron, A.J., Yu, C.H., Crabbe, J.C., 2010. Withdrawal severity after chronic intermittent ethanol in inbred mouse strains. Alcohol. Clin. Exp. Res. 34, 1552-1564.
47. Meyerhoff, D.J., Durazzo, T.C., 2008. Proton magnetic resonance spectroscopy in alcohol use disorders: a potential new endophenotype? Alcohol. Clin. Exp. Res. 32, 1146-1158.
48. Meyerhoff, D.J., Blumenfeld, R., Truran, D., Lindgren, J., Flenniken, D., Cardenas, V., Chao, L.L., Rothlind, J., Studholme, C., Weiner, M.W., 2004. Effects of heavy drinking, binge drinking, and family history of alcoholism on regional brain metabolites. Alcohol. Clin. Exp. Res. 28, 650-661. (Pubitemid 38506901)
49. Moore, G.J., Galloway, M.P., 2002. Magnetic resonance spectroscopy: neurochemistry and treatment effects in affective disorders. Psychopharmacol. Bull. 36, 5-23.
50. Morley, K.C., Teesson, M., Reid, S.C., Sannibale, C., Thomson, C., Phung, N., Weltman, M., Bell, J.R., Richardson, K., Haber, P.S., 2006. Naltrexone versus acamprosate in the treatment of alcohol dependence: a multi-centre, randomized, double-blind, placebo-controlled trial. Addiction 101, 1451-1462. (Pubitemid 44337770)
51. Nagy, L.E., Diamond, I., Casso, D.J., Franklin, C., Gordon, A.S., 1990. Ethanol increases extracellular adenosine by inhibiting adenosine uptake via the nucleoside transporter. J. Biol. Chem. 265, 1946-1951.
52. Nam, H.W., Lee, M.R., Hinton, D.J., Choi, D.-S., 2010. Reduced effect of NMDA glutamate receptor antagonist on ethanol-induced ataxia and striatal glutamate levels in mice lacking ENT1. Neurosci. Lett. 479, 277-281.
53. Nam, H.W., Lee, M.R., Zhu, Y., Wu, J., Hinton, D.J., Choi, S., Kim, T., Hammack, N., Yin, J.C., Choi, D.S., 2011. Type 1 equilibrative nucleoside transporter regulates ethanol drinking through accumbal N-methyl-d-aspartate receptor signaling. Biol. Psychiatry 69, 1043-1051.
54. O'Regan, M.H., Simpson, R.E., Perkins, L.M., Phillis, J.W., 1992. Adenosine receptor agonists inhibit the release of gamma-aminobutyric acid (GABA) from the ischemic rat cerebral cortex. Brain Res. 582, 22-26.
55. Parkinson, F.E., Xiong, W., Zamzow, C.R., Chestley, T., Mizuno, T., Duckworth, M.L., 2009. Transgenic expression of human equilibrative nucleoside transporter 1 in mouse neurons. J. Neurochem. 109, 562-572.
56. Provencher, S.W., 1993. Estimation of metabolite concentrations from localized in vivo proton NMR spectra. Magn. Reson. Med. 30, 672-679. (Pubitemid 23360802)
57. Provencher, S.W., 2001. Automatic quantitation of localized in vivo 1H spectra with LCModel. NMR Biomed. 14, 260-264. (Pubitemid 32611437)
58. Putzke, J., Spanagel, R., Tolle, T.R., Zieglgansberger, W., 1996. The anti-craving drug acamprosate reduces c-fos expression in rats undergoing ethanol withdrawal. Eur. J. Pharmacol. 317, 39-48. (Pubitemid 26427011)
59. Quintanilla, M.E., Perez, E., Tampier, L., 2008. Baclofen reduces ethanol intake in high-alcohol-drinking University of Chile bibulous rats. Addict. Biol. 13, 326-336.
60. Roberto, M., Madamba, S.G., Stouffer, D.G., Parsons, L.H., Siggins, G.R., 2004. Increased GABA release in the central amygdala of ethanol-dependent rats. J. Neurosci. 24, 10159-10166. (Pubitemid 39492041)
61. Rossetti, Z.L., Carboni, S., 1995. Ethanol withdrawal is associated with increased extracellular glutamate in the rat striatum. Eur. J. Pharmacol. 283, 177-183.
62. Spanagel, R., 2009. Alcoholism: a systems approach from molecular physiology to addictive behavior. Physiol. Rev. 89, 649-705.
63. Spanagel, R., Kiefer, F., 2008. Drugs for relapse prevention of alcoholism: ten years of progress. Trends Pharmacol. Sci. 29, 109-115.
64. Stacey, D., Clarke, T.K., Schumann, G., 2009. The genetics of alcoholism. Curr. Psychiatry Rep. 11, 364-369.
65. Swift, R.M., 1999. Medications and alcohol craving. Alcohol Res. Health 23, 207-213.
66. Tabakoff, B., Saba, L., Printz, M., Flodman, P., Hodgkinson, C., Goldman, D., Koob, G., Richardson, H.N., Kechris, K., Bell, R.L., Hubner, N., Heinig, M., Pravenec, M., Mangion, J., Legault, L., Dongier, M., Conigrave, K.M., Whitfield, J.B., Saunders, J., Grant, B., Hoffman, P.L., 2009. Genetical genomic determinants of alcohol consumption in rats and humans. BMC Biol. 7, 70.
67. Thoma, R., Mullins, P., Ruhl, D., Monnig, M., Yeo, R.A., Caprihan, A., Bogenschutz, M., Lysne, P., Tonigan, S., Kalyanam, R., Gasparovic, C., 2011. Perturbation of the glutamate-glutamine system in alcohol dependence and remission. Neuropsychopharmacology 36, 1359-1365.
68. 1H NMR spectroscopy of the mouse brain at 9.4 T. Magn. Reson. Med. 52, 478-484.
69. Tsai, G., Coyle, J.T., 1998. The role of glutamatergic neurotransmission in the pathophysiology of alcoholism. Annu. Rev. Med. 49, 173-184. (Pubitemid 28197448)
70. Tsai, G., Gastfriend, D.R., Coyle, J.T., 1995. The glutamatergic basis of human alcoholism. Am. J. Psychiatry 152, 332-340.
71. Tsai, G.E., Ragan, P., Chang, R., Chen, S., Linnoila, V.M., Coyle, J.T., 1998. Increased glutamatergic neurotransmission and oxidative stress after alcohol withdrawal. Am. J. Psychiatry 155, 726-732. (Pubitemid 28252650)
72. Umhau, J.C., Momenan, R., Schwandt, M.L., Singley, E., Lifshitz, M., Doty, L., Adams, L.J., Vengeliene, V., Spanagel, R., Zhang, Y., Shen, J., George, D.T., Hommer, D., Heilig, M., 2010. Effect of acamprosate on magnetic resonance spectroscopy measures of central glutamate in detoxified alcohol-dependent individuals: a randomized controlled experimental medicine study. Arch. Gen. Psychiatry 67, 1069-1077.